26. Surveillance of Clinical Effectiveness of Transfusion

  1. René R. P. De Vries MD2 and
  2. Jean-Claude Faber MD3
  1. Brian McClelland MD and
  2. Katherine Forrester PhD

Published Online: 6 AUG 2012

DOI: 10.1002/9781118338179.ch26

Hemovigilance: An Effective Tool for Improving Transfusion Safety

Hemovigilance: An Effective Tool for Improving Transfusion Safety

How to Cite

McClelland, B. and Forrester, K. (2012) Surveillance of Clinical Effectiveness of Transfusion, in Hemovigilance: An Effective Tool for Improving Transfusion Safety (eds R. R. P. De Vries and J.-C. Faber), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781118338179.ch26

Editor Information

  1. 2

    Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

  2. 3

    Blood Transfusion Service of the Luxembourg Red Cross, Luxembourg

Author Information

  1. Scottish National Blood Transfusion Service, Edinburgh, UK

Publication History

  1. Published Online: 6 AUG 2012
  2. Published Print: 29 AUG 2012

ISBN Information

Print ISBN: 9780470655276

Online ISBN: 9781118338179

SEARCH

Keywords:

  • surveillance, of clinical effectiveness of transfusion;
  • patient and treatment, potential for hazard in blood transfusions;
  • patients, and net benefit from transfusion;
  • surveillance procedures, and whole transfusion chain;
  • hemovigilance, not providing info on health benefits of transfusion;
  • clinical use of blood components;
  • characteristics of transfused patient population;
  • transfusion and survival in a population;
  • hemovigilance in the future

Summary

This chapter contains sections titled:

  • Introduction

  • Why we transfuse blood components

  • What is meant by hemovigilance

  • Information that would show how transfusion treatment influences the health of a population

  • Hemovigilance in the future

  • References